• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有最小细胞毒性的安全高效的pH敏感型肿瘤靶向修饰脂质体。

Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity.

作者信息

Wang Lilin, Geng Di, Su Haijia

机构信息

State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, 15 Beisanhuan East Road, Chaoyang District, Beijing, China.

Beijing University of Chinese Medicine, 11 Beisanhuan East Road, Chaoyang District, Beijing, China.

出版信息

Colloids Surf B Biointerfaces. 2014 Nov 1;123:395-402. doi: 10.1016/j.colsurfb.2014.09.003. Epub 2014 Sep 15.

DOI:10.1016/j.colsurfb.2014.09.003
PMID:25438693
Abstract

Incorporating the pH-sensitivity of octylamine grafted poly aspartic acid (PASP) with the biocompatibility of liposomes, a novel pH sensitive drug delivery system, octylamine-graft-PASP (PASP-g-C8) modified liposomes (OPLPs), was obtained. Since hydrophobic chains have been grafted into PASP backbones, the octylamine chain could act as the "anchor" to implant onto liposomes. The structure of PASP-g-C8, involving long-chain and hydrophobic anchors can significantly enhance the stability of the drug carrier. The shortcoming of single PASP chain modified liposomes (PLPs), that cannot sustain a slow and controlled release especially in a physiological pH solution (resembling normal tissues of pH 7.4) is thus overcome. Drug release experiments were carried out and the result showed that OPLPs sustained a slow and steady release in comparison with PLPs in the physiological pH 7.4 environment. However, OPLPs can provide a fast release in subacid environment (pH 5.0 of resembled tumor tissues). The results of diameter analysis and zeta potential demonstrated that OPLPs presented a larger diameter and higher electronegativity. Furthermore, in the "chain-anchor" structure of PASP-g-C8, the degree of substitution (DS) of the "anchor" is a remarkable factor to alter the pH-sensitivity of OPLPs. The in vitro tumor inhibition and cell toxicity studies revealed that tumor cells treated with OPLPs survived only 35.0% after 48 h whereas normal cells survived 100% in the same condition. The pH sensitive OPLPs are promising tumor targeting drug delivery with high tumor inhibition and insignificant cytotoxicity.

摘要

将辛胺接枝聚天冬氨酸(PASP)的pH敏感性与脂质体的生物相容性相结合,得到了一种新型的pH敏感药物递送系统——辛胺接枝PASP(PASP-g-C8)修饰脂质体(OPLPs)。由于疏水链已接枝到PASP主链中,辛胺链可作为“锚”植入脂质体。PASP-g-C8的结构包含长链和疏水锚,可显著提高药物载体的稳定性。从而克服了单链PASP修饰脂质体(PLPs)的缺点,尤其是在生理pH溶液(类似于pH 7.4的正常组织)中不能维持缓慢且可控的释放。进行了药物释放实验,结果表明,在生理pH 7.4环境中,与PLPs相比,OPLPs能维持缓慢且稳定的释放。然而,OPLPs在亚酸性环境(类似于肿瘤组织的pH 5.0)中能实现快速释放。粒径分析和zeta电位结果表明,OPLPs具有更大的粒径和更高的负电性。此外,在PASP-g-C8的“链-锚”结构中,“锚”的取代度(DS)是改变OPLPs pH敏感性的一个显著因素。体外肿瘤抑制和细胞毒性研究表明,用OPLPs处理的肿瘤细胞在48小时后存活率仅为35.0%,而在相同条件下正常细胞存活率为100%。这种pH敏感的OPLPs有望成为具有高肿瘤抑制率和低细胞毒性的肿瘤靶向药物递送系统。

相似文献

1
Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity.具有最小细胞毒性的安全高效的pH敏感型肿瘤靶向修饰脂质体。
Colloids Surf B Biointerfaces. 2014 Nov 1;123:395-402. doi: 10.1016/j.colsurfb.2014.09.003. Epub 2014 Sep 15.
2
RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.用于多西他赛肿瘤靶向的RGD修饰的pH敏感脂质体。
Colloids Surf B Biointerfaces. 2015 May 1;129:175-82. doi: 10.1016/j.colsurfb.2015.03.046. Epub 2015 Mar 28.
3
Polymer-hybridized liposomes of poly(amino acid) derivatives as transepidermal carriers.聚合物-杂化脂质体的聚(氨基酸)衍生物作为经皮载体。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:333-8. doi: 10.1016/j.colsurfb.2013.04.047. Epub 2013 May 7.
4
Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.基于 pH 响应穿膜肽和透明质酸的多功能脂质体用于肿瘤靶向抗癌药物递送。
Biomaterials. 2012 Dec;33(36):9246-58. doi: 10.1016/j.biomaterials.2012.09.027. Epub 2012 Sep 29.
5
A high stable pH-temperature dual-sensitive liposome for tuning anticancer drug release.一种用于调节抗癌药物释放的高稳定性pH-温度双敏感脂质体。
Synth Syst Biotechnol. 2020 Jun 14;5(2):103-110. doi: 10.1016/j.synbio.2020.05.004. eCollection 2020 Jun.
6
Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.具有缩醛官能化主链的梳状两亲性嵌段共聚物,在酸性触发下具有疏水到亲水的转变能力,可用作姜黄素细胞内释放的有效纳米载体。
Biomacromolecules. 2013 Nov 11;14(11):3973-84. doi: 10.1021/bm401087n. Epub 2013 Oct 29.
7
A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.一种 pH 响应性 α-螺旋细胞穿透肽介导的脂质体递药系统。
Biomaterials. 2013 Oct;34(32):7980-93. doi: 10.1016/j.biomaterials.2013.07.014. Epub 2013 Jul 24.
8
Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.血浆稳定、pH敏感的促融合聚合物修饰脂质体:米托蒽醌的一种有前景的载体。
J Biomater Appl. 2014 Jul;29(1):81-92. doi: 10.1177/0885328213515288. Epub 2013 Dec 11.
9
Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.载叶酸聚乙二醇接枝-α,β-聚[(N-氨基酸酰基)-天冬酰胺]铂(II)聚合物胶束的抗肿瘤作用研究。
Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):280-8. doi: 10.1016/j.colsurfb.2011.02.040. Epub 2011 Mar 8.
10
Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.用内体 pH 敏感的抗癌脂质体输送抗癌药物。
Biomater Sci. 2016 Apr;4(4):627-38. doi: 10.1039/c5bm00479a. Epub 2016 Jan 25.

引用本文的文献

1
An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restoring cetuximab chemosensitivity.一种用于递送小干扰RNA(siRNA)的基于外泌体的纳米平台,联合饥饿疗法,通过自噬促进肿瘤细胞死亡,克服难治性KRAS突变肿瘤并恢复西妥昔单抗化疗敏感性。
Mater Today Bio. 2025 Apr 10;32:101732. doi: 10.1016/j.mtbio.2025.101732. eCollection 2025 Jun.
2
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
3
Stimuli-Responsive Liposomes of 5-Fluorouracil: Progressive Steps for Safe and Effective Treatment of Colorectal Cancer.5-氟尿嘧啶的刺激响应性脂质体:安全有效治疗结直肠癌的进展
Pharmaceutics. 2024 Jul 22;16(7):966. doi: 10.3390/pharmaceutics16070966.
4
Lipid-engineered nanotherapeutics for cancer management.用于癌症治疗的脂质工程纳米疗法。
Front Pharmacol. 2023 Mar 23;14:1125093. doi: 10.3389/fphar.2023.1125093. eCollection 2023.
5
A high stable pH-temperature dual-sensitive liposome for tuning anticancer drug release.一种用于调节抗癌药物释放的高稳定性pH-温度双敏感脂质体。
Synth Syst Biotechnol. 2020 Jun 14;5(2):103-110. doi: 10.1016/j.synbio.2020.05.004. eCollection 2020 Jun.
6
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.全身真菌感染的抗真菌治疗与纳米生物技术时代:提高疗效、改善生物分布及降低毒性
Front Microbiol. 2017 Mar 7;8:336. doi: 10.3389/fmicb.2017.00336. eCollection 2017.
7
Stimuli-responsive liposomes for drug delivery.用于药物递送的刺激响应型脂质体。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5). doi: 10.1002/wnan.1450. Epub 2017 Feb 15.
8
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.癌症治疗中的脂质基药物递送系统:现状与未来展望
Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070.
9
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.用于索拉非尼和siRNA共递送的pH敏感型羧甲基壳聚糖修饰阳离子脂质体
Int J Nanomedicine. 2015 Oct 1;10:6185-97. doi: 10.2147/IJN.S90524. eCollection 2015.
10
Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.靶向肿瘤微环境中的癌细胞:组合纳米医学的机遇与挑战
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):208-22. doi: 10.1002/wnan.1358. Epub 2015 Jul 7.